InvestorsHub Logo
Followers 4
Posts 1190
Boards Moderated 0
Alias Born 10/03/2015

Re: NY1972 post# 201

Wednesday, 05/18/2016 6:18:38 PM

Wednesday, May 18, 2016 6:18:38 PM

Post# of 977
IDO/gemcitabine / nab-paclitaxel for the treatment of metastatic pancreas cancer

At this interim analysis, 30 patients to date have been enrolled in Phase 1 / 2 and completed protocol treatment at least through imaging at the end of cycle 2. Of these, 11 (37%) have demonstrated an objective response by RECIST criteria including one patient with a confirmed complete response. One adverse event of immunological significance (colitis) was observed and required study withdrawl.

http://abstracts.asco.org/176/AbstView_176_170916.html